Inventor · disambiguated record
Xin Lu
Also filed as: LU XIN · LU XIN LUCAS
16 granted patents·18 pending applications·19 citations·filing 1997–2021
88Inventor score
Files withLUDWIG INST CANCER RES7SEMIZAROV DIMITRI7LU XIN5ABBOTT MOLECULAR INC2DANA FARBER CANCER INST INC2
Top patents by PatentIndex Score
34 records- 0191US10047403B2Diagnostic methods for determining prognosis of non-small cell lung cancerABBOTT MOLECULAR INC·Filed 2016·Granted Aug 14, 2018·5 cites·11 claims
- 0278US9291625B2Diagnostic methods for determining prognosis of non-small cell lung cancerSEMIZAROV DIMITRI·Filed 2010·Granted Mar 22, 2016·3 cites·11 claims
- 0376US8498822B2Genomic classification of colorectal cancer based on patterns of gene copy number alterationsSEMIZAROV DIMITRI·Filed 2009·Granted Jul 30, 2013·1 cites·9 claims
- 0476US8498820B2Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterationsSEMIZAROV DIMITRI·Filed 2009·Granted Jul 30, 2013·1 cites·9 claims
- 0566US7745571B2Peptide inhibitors of IASPPLUDWIG INST CANCER RES·Filed 2008·Granted Jun 29, 2010·0 cites·16 claims
- 0666US2010233171A1Differential Drug SensitivityLU XIN·Filed 2009·Application pending·0 cites
- 0762US9687548B2Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereofDANA FARBER CANCER INST INC·Filed 2013·Granted Jun 27, 2017·0 cites·17 claims
- 0862US9002653B2Methods for assembling panels of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositionsSEMIZAROV DIMITRI·Filed 2009·Granted Apr 7, 2015·3 cites·5 claims
- 0959US8498821B2Genomic classification of malignant melanoma based on patterns of gene copy number alterationsSEMIZAROV DIMITRI·Filed 2009·Granted Jul 30, 2013·0 cites·9 claims
- 1056US2005260629A1Differential drug sensitivityLUDWIG INST CANCER RES·Filed 2005·Application pending·0 cites
- 1156US2017340736A1Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereofDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1255US7645859B2Tumour suppressor proteinLUDWIG INST CANCER RES·Filed 2004·Granted Jan 12, 2010·1 cites·5 claims
- 1354US2024325539A1Methods and compositions for treating epstein barr virus-associated cancerTHE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIV OF OXFORD·Filed 2021·Application pending·0 cites
- 1454US2017096714A1Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancerABBOTT MOLECULAR INC·Filed 2016·Application pending·0 cites
- 1552US2005227918A1Method for assaying susceptibility to cancer therapy in a subject by assaying for tumors of P53FARRELL PAUL J·Filed 2004·Application pending·0 cites
- 1650US7723019B2Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereofUNIV KENTUCKY RES FOUND·Filed 2006·Granted May 25, 2010·0 cites·7 claims
- 1749US2006100143A1PolypeptideLU XIN·Filed 2003·Application pending·0 cites
- 1849US2010047868A1Tumour Suppressor ProteinLU XIN·Filed 2009·Application pending·0 cites
- 1948US2005123977A1Assay and treatmentLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 2048US2004053262A1Supressor geneFiled 2001·Application pending·0 cites
- 2148US2006064768A1Murine Pten null prostate cancer modelUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 2247US9752196B2Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancerPESTOVA EKATERINA·Filed 2010·Granted Sep 5, 2017·0 cites·11 claims
- 2347US8742083B1Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263SEMIZAROV DIMITRI·Filed 2010·Granted Jun 3, 2014·0 cites·9 claims
- 2447US2004228866A1Suppressor genesLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 2545US9297045B2Diagnostic methods for determining prognosis of non-small cell lung cancerSEMIZAROV DIMITRI·Filed 2010·Granted Mar 29, 2016·0 cites·9 claims
- 2645US2008193488A1Variant Polypeptide and Screening AssayLUDWIG INST CANCER RES·Filed 2006·Application pending·0 cites
- 2744US9880171B2iASPP phosphorylation and metastatic potentialLUDWIG INST FOR CANCER RES LTD·Filed 2013·Granted Jan 30, 2018·0 cites·45 claims
- 2844US2019231893A1Methods of treating cancerABBVIE INC·Filed 2018·Application pending·0 cites
- 2942US2016160298A1Diagnostic methods for determining prognosis of non-small cell lung cancerABBOTT LAB·Filed 2016·Application pending·0 cites
- 3042US2006127401A1Screening methodLU XIN·Filed 2003·Application pending·0 cites
- 3140US2020217849A1Capture of circulating tumor cells using carbon nanotube spongesWEI BINGQING·Filed 2018·Application pending·0 cites
- 3240US2007225240A1Screening Assay and TreatmentLU XIN·Filed 2004·Application pending·0 cites
- 3336US8318441B2Fibrinogen alpha and hemoglobin polypeptides as cancer markersMIRON ALEXANDER·Filed 2010·Granted Nov 27, 2012·0 cites·15 claims
- 3436US6204253B1Factors which interact with oncoproteinsLUDWIG INST CANCER RES·Filed 1997·Granted Mar 20, 2001·5 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Xin Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →